accession	uid	title	organization	taxonomy	sra	geo	cell line	source_name	treatment
SAMN13633919	13633919	SW6ODC2	iGE3 Genomics Platform, University of Geneva	9606	SRS5863498	GSM4225689	SW620	CRC cell line	ODC (regorafenib, vemurafenib)
SAMN13633920	13633920	SW6ODC1	iGE3 Genomics Platform, University of Geneva	9606	SRS5863521	GSM4225688	SW620	CRC cell line	ODC (regorafenib, vemurafenib)
SAMN13633921	13633921	SW6CTRL2	iGE3 Genomics Platform, University of Geneva	9606	SRS5863497	GSM4225687	SW620	CRC cell line	CTRL
SAMN13633922	13633922	SW6CTRL1	iGE3 Genomics Platform, University of Geneva	9606	SRS5863496	GSM4225686	SW620	CRC cell line	CTRL
SAMN13633923	13633923	SW4ODC2	iGE3 Genomics Platform, University of Geneva	9606	SRS5863495	GSM4225685	SW48	CRC cell line	ODC (vemurafenib, crenolanib)
SAMN13633924	13633924	SW4ODC1	iGE3 Genomics Platform, University of Geneva	9606	SRS5863494	GSM4225684	SW48	CRC cell line	ODC (vemurafenib, crenolanib)
SAMN13633926	13633926	SW4CTRL2	iGE3 Genomics Platform, University of Geneva	9606	SRS5863493	GSM4225683	SW48	CRC cell line	CTRL
SAMN13633928	13633928	SW4CTRL1	iGE3 Genomics Platform, University of Geneva	9606	SRS5863503	GSM4225682	SW48	CRC cell line	CTRL
SAMN13633930	13633930	LSODC2	iGE3 Genomics Platform, University of Geneva	9606	SRS5863492	GSM4225681	LS174T	CRC cell line	ODC (regorafenib, GDC-0994)
SAMN13633932	13633932	LSODC1	iGE3 Genomics Platform, University of Geneva	9606	SRS5863490	GSM4225680	LS174T	CRC cell line	ODC (regorafenib, GDC-0994)
SAMN13633934	13633934	LSCTRL2	iGE3 Genomics Platform, University of Geneva	9606	SRS5863489	GSM4225679	LS174T	CRC cell line	CTRL
SAMN13633936	13633936	LSCTRL1	iGE3 Genomics Platform, University of Geneva	9606	SRS5863488	GSM4225678	LS174T	CRC cell line	CTRL
SAMN13633937	13633937	HTODC2	iGE3 Genomics Platform, University of Geneva	9606	SRS5863487	GSM4225677	HT29	CRC cell line	ODC (regorafenib, AZD-4547, vatalanib)
SAMN13633939	13633939	HTODC1	iGE3 Genomics Platform, University of Geneva	9606	SRS5863486	GSM4225676	HT29	CRC cell line	ODC (regorafenib, AZD-4547, vatalanib)
SAMN13633940	13633940	HTCTRL2	iGE3 Genomics Platform, University of Geneva	9606	SRS5863485	GSM4225675	HT29	CRC cell line	CTRL
SAMN13633942	13633942	HTCTRL1	iGE3 Genomics Platform, University of Geneva	9606	SRS5863483	GSM4225674	HT29	CRC cell line	CTRL
SAMN13633944	13633944	HCTODC2	iGE3 Genomics Platform, University of Geneva	9606	SRS5863499	GSM4225673	HCT116	CRC cell line	ODC (regorafenib, vemurafenib, GDC-0994)
SAMN13633946	13633946	HCTODC1	iGE3 Genomics Platform, University of Geneva	9606	SRS5863482	GSM4225672	HCT116	CRC cell line	ODC (regorafenib, vemurafenib, GDC-0994)
SAMN13633947	13633947	HCTCTRL2	iGE3 Genomics Platform, University of Geneva	9606	SRS5863481	GSM4225671	HCT116	CRC cell line	CTRL
SAMN13633948	13633948	HCTCTRL1	iGE3 Genomics Platform, University of Geneva	9606	SRS5863480	GSM4225670	HCT116	CRC cell line	CTRL
SAMN13633949	13633949	DLDODC2	iGE3 Genomics Platform, University of Geneva	9606	SRS5863479	GSM4225669	DLD1	CRC cell line	ODC (regorafenib, selumetinib)
SAMN13633950	13633950	DLDODC1	iGE3 Genomics Platform, University of Geneva	9606	SRS5863478	GSM4225668	DLD1	CRC cell line	ODC (regorafenib, selumetinib)
SAMN13633951	13633951	DLDCTRL1	iGE3 Genomics Platform, University of Geneva	9606	SRS5863477	GSM4225667	DLD1	CRC cell line	CTRL
SAMN13633952	13633952	DLDCTR2	iGE3 Genomics Platform, University of Geneva	9606	SRS5863476	GSM4225666	DLD1	CRC cell line	CTRL